the oncology institute of hope and innovation is a premier cancer treatment center in los angeles. offering programs to help patients and families cope with the challenges that are brought on by cancer and strive to optimize their quality of life, comprehensive and realistic treatment goals are tailored to every person's unique needs and decided upon in partnership with the patients and their families. dedicated to excel in cancer prevention, diagnosis and education through our exceptional team of physicians, nurse practitioners, nurses, medical assistants and office staff, the oncology institute of hope and innovation has 8 southern california locations in the cities of downey, long beach, lynwood, montebello whittier, anaheim, la mirada and glendale. for more information please visit www.theoncologyinstitute.com.
Company profile
Ticker
TOI, TOIIW
Exchange
Website
CEO
Steven I. Hochberg
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
DFP HEALTHCARE ACQUISITIONS CORP.
SEC CIK
TOI stock data
Latest filings (excl ownership)
8-K
1THE ONCOLOGY INSTITUTE OF HOPE & INNOVATION Investor Presentation April 2024
3 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
8-K
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
27 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
The Oncology Institute Reports Third Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance
8 Nov 23
8-K
Other Events
18 Sep 23
8-K
Departure of Directors or Certain Officers
6 Sep 23
8-K
Departure of Directors or Certain Officers
1 Sep 23
8-K
Other Events
30 Aug 23
8-K
1THE ONCOLOGY INSTITUTE OF HOPE & INNOVATION Investor Presentation AUGUST 2023
10 Aug 23
Transcripts
TOI
Earnings call transcript
2023 Q4
27 Mar 24
TOI
Earnings call transcript
2023 Q3
8 Nov 23
TOI
Earnings call transcript
2023 Q2
8 Aug 23
TOI
Earnings call transcript
2023 Q1
10 May 23
TOI
Earnings call transcript
2022 Q4
9 Mar 23
TOI
Earnings call transcript
2022 Q3
12 Nov 22
TOI
Earnings call transcript
2022 Q2
12 Aug 22
TOI
Earnings call transcript
2022 Q1
12 May 22
TOI
Earnings call transcript
2021 Q4
11 Mar 22
Latest ownership filings
4
Change in insider ownership
30 Jan 24
4
Change in insider ownership
26 Jan 24
4
Change in insider ownership
23 Jan 24
144
Notice of proposed sale of securities
19 Jan 24
SC 13D/A
Havencrest Healthcare Partners, L.P.
2 Jan 24
4
Change in insider ownership
2 Jan 24
4
RICHARD A BARASCH
28 Dec 23
4
Brad Hively
28 Dec 23
4
Karen Marie Johnson
28 Dec 23
4
Mohit Kaushal
28 Dec 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 27.54 mm | 27.54 mm | 27.54 mm | 27.54 mm | 27.54 mm | 27.54 mm |
Cash burn (monthly) | 452.33 k | 2.82 mm | 5.76 mm | 7.67 mm | 2.77 mm | 3.87 mm |
Cash used (since last report) | 3.02 mm | 18.85 mm | 38.46 mm | 51.19 mm | 18.49 mm | 25.82 mm |
Cash remaining | 24.52 mm | 8.68 mm | -10.92 mm | -23.66 mm | 9.04 mm | 1.71 mm |
Runway (months of cash) | 54.2 | 3.1 | -1.9 | -3.1 | 3.3 | 0.4 |
Institutional ownership, Q3 2023
38.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 50 |
Opened positions | 33 |
Closed positions | 2 |
Increased positions | 5 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 21.45 bn |
Total shares | 28.24 mm |
Total puts | 0.00 |
Total calls | 162.10 k |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
FMR | 4.75 mm | $6.66 bn |
FOG Ventures Investments | 4.63 mm | $0.00 |
Deerfield Management | 4.61 mm | $4.82 bn |
Ravi Yang Sarin | 4.11 mm | $0.00 |
Josh Arnold Investment Consultant | 2.27 mm | $2.68 bn |
Vanguard | 1.76 mm | $2.46 bn |
LMR Partners | 1.59 mm | $146.43 mm |
Hongkou Capital | 904.69 k | $1.27 bn |
Balyasny Asset Management | 437.58 k | $612.61 mm |
Tiff Advisory Services | 423.41 k | $592.77 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jan 24 | Havencrest Healthcare Partners | Common stock | Sell | Dispose S | Yes | No | 2.12 | 8,637 | 18.31 k | 0 |
26 Jan 24 | Havencrest Healthcare Partners | Common stock | Sell | Dispose S | Yes | No | 2.14 | 6,979 | 14.94 k | 8,637 |
25 Jan 24 | Havencrest Healthcare Partners | Common stock | Sell | Dispose S | Yes | No | 2.07 | 11,882 | 24.60 k | 15,616 |
24 Jan 24 | Havencrest Healthcare Partners | Common stock | Sell | Dispose S | Yes | No | 2.3 | 24,915 | 57.30 k | 27,498 |
23 Jan 24 | Havencrest Healthcare Partners | Common stock | Sell | Dispose S | Yes | No | 2.11 | 5,338 | 11.26 k | 52,413 |
22 Jan 24 | Havencrest Healthcare Partners | Common stock | Sell | Dispose S | Yes | No | 2.12 | 10,263 | 21.76 k | 57,751 |
19 Jan 24 | Havencrest Healthcare Partners | Common stock | Sell | Dispose S | Yes | No | 2.13 | 11,986 | 25.53 k | 68,014 |
28 Dec 23 | Havencrest Healthcare Partners | Common stock | Other | Dispose J | Yes | No | 0 | 3,999,998 | 0.00 | 8,881,823 |
28 Dec 23 | Havencrest Healthcare Partners | Common stock | Other | Dispose J | Yes | No | 0 | 4,561,050 | 0.00 | 12,801,821 |
26 Dec 23 | Mark L Pacala | Common stock | Grant | Acquire A | No | No | 0 | 46,630 | 0.00 | 135,029 |
News
12 Health Care Stocks Moving In Thursday's Intraday Session
28 Mar 24
Recap: Oncology Institute Q4 Earnings
27 Mar 24
The Oncology Institute Q4 2023 GAAP EPS $(0.21) Misses $(0.11) Estimate, Sales $85.788M Beat $82.042M Estimate
27 Mar 24
Earnings Scheduled For March 27, 2024
27 Mar 24
Earnings Outlook For The Oncology Institute
26 Mar 24
Press releases
The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024
27 Mar 24
MaxHealth & The Oncology Institute Expand Value-Based Care Partnership
14 Mar 24
WellBe Senior Medical Partners with The Oncology Institute to Extend High-Value Cancer Care Services Across Illinois and Ohio
25 Jan 24